On May 1, 2026, Jaguar Health, Inc. received a notice from Nasdaq stating it does not meet the minimum requirement of 500,000 publicly held shares following a reverse stock split effective April 30, 2026, putting its listing at risk. The company must address this deficiency by May 8, 2026 to avoid delisting.